Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Diseases, Alcoholic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04505436
What this trial is testing

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hanmi Pharmaceutical Company Limited 215
Early research (Phase 1)Study completedNCT00816465
What this trial is testing

Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hadassah Medical Organization 20
Not applicableStudy completedNCT04180631
What this trial is testing

Quantitative US for Hepatic Steatosis

Who this might be right for
Hepatic Steatosis
Seoul National University Hospital 124
Testing effectiveness (Phase 2)Study completedNCT04321031
What this trial is testing

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis With Liver Fibrosis
Pfizer 256
Early research (Phase 1)Study completedNCT03681457
What this trial is testing

Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)UnknownNCT01617772
What this trial is testing

Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Tehran University of Medical Sciences 440
Not applicableStudy completedNCT04988230
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Not applicableStudy completedNCT01820819
What this trial is testing

Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?

Who this might be right for
Inpatient With End Stage Liver Disease
Assistance Publique - Hôpitaux de Paris 574
Not applicableLooking for participantsNCT04442334
What this trial is testing

The European NAFLD Registry

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+9 more
Newcastle University 10,000
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Large-scale testing (Phase 3)UnknownNCT03069300
What this trial is testing

N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis

Who this might be right for
Alcoholic HepatitisInfection
Imperial College London 42
Not applicableStudy completedNCT02363309
What this trial is testing

Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 74
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableLooking for participantsNCT06814600
What this trial is testing

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Who this might be right for
NAFLDInflammatory Bowel DiseasesSteatosis+1 more
Centre Hospitalier Universitaire Saint Pierre 150
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Not applicableUnknownNCT05359471
What this trial is testing

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD

Who this might be right for
Visceral SteatosisHivNAFLD
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Next Page